NCT05711667 2026-02-24
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
Children's Oncology Group
Phase 3 Recruiting
Children's Oncology Group
Center for International Blood and Marrow Transplant Research
AIDS Malignancy Consortium